Dynex Capital, Inc. (NYSE:DX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six analysts that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $13.35.
A number of research analysts have weighed in on the company. JMP Securities restated a “market perform” rating on shares of Dynex Capital in a research note on Wednesday, August 28th. StockNews.com cut Dynex Capital from a “hold” rating to a “sell” rating in a research report on Wednesday, July 31st.
Read Our Latest Stock Analysis on DX
Dynex Capital Stock Up 0.4 %
Dynex Capital (NYSE:DX – Get Free Report) last posted its quarterly earnings results on Monday, October 21st. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.39). The company had revenue of $83.46 million during the quarter, compared to the consensus estimate of $4.92 million. Dynex Capital had a net margin of 28.83% and a negative return on equity of 4.80%. During the same quarter in the prior year, the business earned ($0.28) earnings per share. On average, sell-side analysts expect that Dynex Capital will post 1.03 EPS for the current fiscal year.
Dynex Capital Increases Dividend
The company also recently declared a monthly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 22nd will be issued a dividend of $0.15 per share. This is a boost from Dynex Capital’s previous monthly dividend of $0.13. This represents a $1.80 annualized dividend and a yield of 14.43%. The ex-dividend date of this dividend is Friday, November 22nd. Dynex Capital’s dividend payout ratio (DPR) is presently 142.86%.
Institutional Trading of Dynex Capital
Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Dynex Capital by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 3,042,634 shares of the real estate investment trust’s stock worth $37,881,000 after purchasing an additional 41,586 shares during the last quarter. Millennium Management LLC raised its holdings in Dynex Capital by 62.1% in the 2nd quarter. Millennium Management LLC now owns 2,575,848 shares of the real estate investment trust’s stock valued at $30,756,000 after acquiring an additional 986,471 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Dynex Capital by 7.0% in the 3rd quarter. Victory Capital Management Inc. now owns 2,092,808 shares of the real estate investment trust’s stock valued at $26,704,000 after acquiring an additional 136,776 shares in the last quarter. Geode Capital Management LLC raised its holdings in Dynex Capital by 17.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,701,740 shares of the real estate investment trust’s stock valued at $21,718,000 after acquiring an additional 253,660 shares in the last quarter. Finally, State Street Corp raised its holdings in Dynex Capital by 2.9% in the 3rd quarter. State Street Corp now owns 1,550,115 shares of the real estate investment trust’s stock valued at $19,977,000 after acquiring an additional 44,302 shares in the last quarter. 38.34% of the stock is owned by institutional investors and hedge funds.
About Dynex Capital
Dynex Capital, Inc, a mortgage real estate investment trust, invests in mortgage-backed securities (MBS) on a leveraged basis in the United States. It invests in agency and non-agency MBS consisting of residential MBS, commercial MBS (CMBS), and CMBS interest-only securities. Agency MBS have a guaranty of principal payment by an agency of the U.S.
Read More
- Five stocks we like better than Dynex Capital
- Financial Services Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Nasdaq? Complete Overview with History
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Dynex Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynex Capital and related companies with MarketBeat.com's FREE daily email newsletter.